Status:
RECRUITING
qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
Siemens Medical Solutions
Conditions:
Transarterial Embolism
Transarterial Chemoembolization
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research is to evaluate a new technique, quantitative digital subtraction angiography (qDSA), to measure blood flow during liver embolization procedures. Liver transarterial emboli...
Eligibility Criteria
Inclusion
- Give voluntary, written informed consent to participate in this study and willing to comply with study-related evaluation and procedure schedule
Exclusion
- Pregnancy or breastfeeding
- Patients with an acute kidney injury or stage IV or V chronic kidney disease (Cr greater than 2.4 or estimated glomerular filtration rate (eGFR) less than 30), unless anuric and on dialysis without expected return of renal function.
- Patients with an iodinated contrast allergy who cannot be adequately premedicated to receive contrast as part of the embolization procedure.
- Patients with a physical or psychological condition that would impair study participation.
- The patient is judged unsuitable for study participation by the Investigator for any other reason
Key Trial Info
Start Date :
March 13 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06971991
Start Date
March 13 2025
End Date
March 1 2026
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UW Hospital and Clinics
Madison, Wisconsin, United States, 53792